Sounak Gupta, M.B.B.S., Ph.D., explains how Mayo Clinic Laboratories' gynecological NGS panels provide focused assessments of gynecological cancers. The cost-effective tests fill the gap between single gene assays and large cancer panels, to inform prognosis and treatment.
 
(00:32)
 Could you provide our listeners with a little bit about yourself and your background, please?

(01:22)
 Could you give a brief overview of the new assays?

(03:55)
 Can you talk a little about both the ovarian and gynecologic panel that will be in the new set of tests?

(05:53)
 What patients will be impacted by this testing?

(07:51)
 Can you speak to some of the individual genes in the gynecological area, such as POLE?

(09:31)
 Is there anything else you would like to add?